z-logo
open-access-imgOpen Access
RIT1 oncoproteins escape LZTR1-mediated proteolysis
Author(s) -
Pau Castel,
Alice Cheng,
Antonio Cuevas-Navarro,
David B. Everman,
Alex G. Papageorge,
Dhirendra K. Simanshu,
Alexandra Tankka,
Jacqueline Galeas,
Anatoly Urisman,
Frank McCormick
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aav1444
Subject(s) - proteolysis , chemistry , biochemistry , enzyme
Defective degradation as disease mechanism Ubiquitination often targets proteins for destruction. Castelet al. describe a mechanism by which mutations in the small guanine triphosphatase RIT1 may act to cause certain developmental disorders and cancers. They detected a protein, LZTR1, that interacted with wild-type RIT1 but not with oncogenic mutant forms of RIT1. LZTR1 acts as a substrate-specific adaptor for a ubiquitin ligase. Altered forms of RIT1 that are not subject to ubiquitin-mediated degradation thus accumulate. Because RIT1 functions in growth factor signaling and excessive signaling, these findings may explain the malignancies associated with RIT1 mutations.Science , this issue p.1226

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom